Overview
AGL Energy (ASX: AGL) has experienced a significant surge in its share price following the release of its first-half FY24 results, which exceeded earnings and dividend expectations while tightening its guidance towards the upper end of previous forecasts.
Earnings Outperformance
AGL's first-half FY24 results have surpassed expectations, with underlying EBITDA reaching $1,074 million, a remarkable 78% increase year-on-year, and underlying net profit after tax hitting $399 million, marking a 359% rise. The interim dividend of 26 cents per share also exceeded estimates, reflecting a targeted 50% payout ratio of underlying net profit.
Guidance Adjustment
The company has tightened its full-year guidance, expecting EBITDA between $2,025-2,175 million and net profit after tax between $680-780 million. This adjustment reflects a strong performance in the first half, driven by improved operational efficiency and higher wholesale electricity pricing, although partially offset by inflation and other investments.
Market Response
AGL shares opened 13.0% higher, reaching $9.02, and although gains eased slightly, they remained substantial. Analysts at Macquarie, while retaining a Neutral rating, adjusted their target price to $9.30, acknowledging the positive impact of the results but expressing caution regarding future earnings growth in the absence of electricity price rallies.
Cochlear's Unexpected Upgrade
In contrast, Cochlear (ASX: COH) shares rallied 5.5% after the company unexpectedly upgraded its FY24 guidance amidst strong trading conditions and market share gains. Despite recent broker downgrades, Cochlear's upgraded forecast of $385-400 million in underlying net profit reflects robust performance and market growth.
Analyst Sentiment
Broker downgrades of Cochlear were driven by concerns over elevated valuations and desired evidence of increased sales growth. However, the unexpected upgrade may prompt analysts to revisit their target prices and ratings in the coming days.
Conclusion
The contrasting performances of AGL Energy and Cochlear highlight the volatility and dynamics of the Australian stock market. While AGL's exceptional results propelled its shares upward, Cochlear's unexpected upgrade defied recent pessimism, suggesting potential revisions in analyst sentiment and target prices. Investors await further developments and adjustments in response to these significant market movements.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Feb 21, 2025
Feb 21, 2025
Feb 20, 2025
Feb 20, 2025
Feb 20, 2025
Feb 18, 2025
Feb 18, 2025
Feb 18, 2025
Feb 17, 2025
Feb 17, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.